Literature DB >> 11527820

Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.

B Trollfors1, T Lagergård, J Taranger, E Bergfors, R Schneerson, J B Robbins.   

Abstract

Serum immunoglobulin G (IgG) antibodies against the lipooligosaccharide (LOS) of Bordetella pertussis and the lipopolysaccharide (LPS) of Bordetella parapertussis were measured by enzyme-linked immunosorbent assay in paired sera from 40 children with pertussis and 14 with parapertussis. Wide differences in the individual responses were noted. Both anti-LOS and -LPS IgG levels increased significantly in the children with pertussis, as did anti-LPS but not anti-LOS in those with parapertussis.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11527820      PMCID： PMC96188          DOI： 10.1128/CDLI.8.5.1015-1017.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  19 in total

1.  Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis.

Authors:  D W Byrd; R M Roop; H P Veit; G G Schurig
Journal:  J Med Microbiol       Date:  1991-03       Impact factor: 2.472

2.  Analysis of antibody profiles in children with whooping cough.

Authors:  P Novotny; M E Macaulay; T C Hart; F Skvaril
Journal:  Dev Biol Stand       Date:  1991

3.  Biological activity of a human monoclonal antibody to Bordetella pertussis lipooligosaccharide.

Authors:  B R Brodeur; J Hamel; D Martin; P Rondeau
Journal:  Hum Antibodies Hybridomas       Date:  1991-10

4.  Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes.

Authors:  B Aricò; R Rappuoli
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

5.  Biological properties of lipopolysaccharides from Bordetella species.

Authors:  M Watanabe; H Takimoto; Y Kumazawa; K Amano
Journal:  J Gen Microbiol       Date:  1990-03

6.  Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.

Authors:  E T Harvill; A Preston; P A Cotter; A G Allen; D J Maskell; J F Miller
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses.

Authors:  E Bergfors; B Trollfors; J Taranger; T Lagergård; V Sundh; G Zackrisson
Journal:  Int J Infect Dis       Date:  1999       Impact factor: 3.623

8.  Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features.

Authors:  M Caroff; R Chaby; D Karibian; J Perry; C Deprun; L Szabó
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

9.  Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis.

Authors:  K S Marchitto; S G Smith; C Locht; J M Keith
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

10.  Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants.

Authors:  M S Peppler
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441
View more
  6 in total

1.  Toward a new vaccine for pertussis.

Authors:  John B Robbins; Rachel Schneerson; Joanna Kubler-Kielb; Jerry M Keith; Birger Trollfors; Evgeny Vinogradov; Joseph Shiloach
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-20       Impact factor: 11.205

Review 2.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Teresa Lagergård; Ariel Ginzberg; Jerry D King; Andrew Preston; Duncan J Maskell; Vince Pozsgay; Jerry M Keith; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

4.  Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate.

Authors:  Tomasz Niedziela; Iwona Letowska; Jolanta Lukasiewicz; Marta Kaszowska; Anna Czarnecka; Lennart Kenne; Czeslaw Lugowski
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  Respiratory disease in kennelled dogs: serological responses to Bordetella bronchiseptica lipopolysaccharide do not correlate with bacterial isolation or clinical respiratory symptoms.

Authors:  Victoria J Chalker; Crista Toomey; Shaun Opperman; Harriet W Brooks; Michael A Ibuoye; Joe Brownlie; Andrew N Rycroft
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

6.  Structure and Immunogenicity of the Bordetella pertussis LOS-Derived Oligosaccharides in the Endosomal-Like Pre-Processing Mice Model.

Authors:  Sabina Koj; Karolina Ucieklak; Czeslaw Lugowski; Tomasz Niedziela
Journal:  Vaccines (Basel)       Date:  2021-06-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.